tnya: the income statement

MyFinsight

Tenaya Therapeutics, Inc. (TNYA)

For the quarter ending 2025-06-30, TNYA made $824K in revenue. -$23,274K in net income. Net profit margin of -2824.51%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Net unrealized gain (loss) on marketable securities	9
Research and development	17,370
General and administrative	6,712
Total operating expenses	24,082
Loss from operations	-24,082
Other income (loss), net	-16
Interest income	815
Total other income, net	799
Net loss before income tax expense	-23,283
Net loss	-23,283
Comprehensive loss	-23,274

Net loss per share, basic	-0.14
Net loss per share, diluted	-0.14
Weighted-average shares used in computing net loss per share, basic	162,791,579
Weighted-average shares used in computing net loss per share, diluted	162,791,579

Unit: Thousand (K) dollars (except for numbers of shares and EPS)